Chang L - Search Results

1

Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy.

Hao J, Graham P, Chang L, Ni J, Wasinger V, Beretov J, Deng J, Duan W, Bucci J, Malouf D, Gillatt D, Li Y. Hao J, et al. Among authors: chang l. Oncotarget. 2016 Nov 8;7(45):74269-74285. doi: 10.18632/oncotarget.12368. Oncotarget. 2016. PMID: 27708237 Free PMC article.

2

In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147.

Hao J, Madigan MC, Khatri A, Power CA, Hung TT, Beretov J, Chang L, Xiao W, Cozzi PJ, Graham PH, Kearsley JH, Li Y. Hao J, et al. Among authors: chang l. PLoS One. 2012;7(8):e40716. doi: 10.1371/journal.pone.0040716. Epub 2012 Aug 3. PLoS One. 2012. PMID: 22870202 Free PMC article.

3

Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro.

Chao H, Wang L, Hao J, Ni J, Chang L, Graham PH, Kearsley JH, Li Y. Chao H, et al. Among authors: chang l. Cancer Lett. 2013 Feb 1;329(1):17-26. doi: 10.1016/j.canlet.2012.08.035. Epub 2012 Sep 18. Cancer Lett. 2013. PMID: 22995071

4

Combination therapy with the histone deacetylase inhibitor LBH589 and radiation is an effective regimen for prostate cancer cells.

Xiao W, Graham PH, Hao J, Chang L, Ni J, Power CA, Dong Q, Kearsley JH, Li Y. Xiao W, et al. Among authors: chang l. PLoS One. 2013 Aug 26;8(8):e74253. doi: 10.1371/journal.pone.0074253. eCollection 2013. PLoS One. 2013. PMID: 23991216 Free PMC article.

5

Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.

Ni J, Cozzi P, Hao J, Beretov J, Chang L, Duan W, Shigdar S, Delprado W, Graham P, Bucci J, Kearsley J, Li Y. Ni J, et al. Among authors: chang l. Int J Biochem Cell Biol. 2013 Dec;45(12):2736-48. doi: 10.1016/j.biocel.2013.09.008. Epub 2013 Sep 25. Int J Biochem Cell Biol. 2013. PMID: 24076216

6

Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.

Chang L, Graham PH, Hao J, Bucci J, Cozzi PJ, Kearsley JH, Li Y. Chang L, et al. Cancer Metastasis Rev. 2014 Sep;33(2-3):469-96. doi: 10.1007/s10555-014-9493-5. Cancer Metastasis Rev. 2014. PMID: 24445654 Review.

7

CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance.

Ni J, Cozzi PJ, Hao JL, Beretov J, Chang L, Duan W, Shigdar S, Delprado WJ, Graham PH, Bucci J, Kearsley JH, Li Y. Ni J, et al. Among authors: chang l. Prostate. 2014 May;74(6):602-17. doi: 10.1002/pros.22775. Epub 2014 Feb 12. Prostate. 2014. PMID: 24615685

8

Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance.

Chang L, Graham PH, Ni J, Hao J, Bucci J, Cozzi PJ, Li Y. Chang L, et al. Crit Rev Oncol Hematol. 2015 Dec;96(3):507-17. doi: 10.1016/j.critrevonc.2015.07.005. Epub 2015 Jul 18. Crit Rev Oncol Hematol. 2015. PMID: 26253360 Review.

9

Proteomics discovery of radioresistant cancer biomarkers for radiotherapy.

Chang L, Graham P, Hao J, Bucci J, Malouf D, Gillatt D, Li Y. Chang L, et al. Cancer Lett. 2015 Dec 28;369(2):289-97. doi: 10.1016/j.canlet.2015.09.013. Epub 2015 Sep 30. Cancer Lett. 2015. PMID: 26427840 Review.

10

Cancer stem cells and signaling pathways in radioresistance.

Chang L, Graham P, Hao J, Ni J, Deng J, Bucci J, Malouf D, Gillatt D, Li Y. Chang L, et al. Oncotarget. 2016 Mar 8;7(10):11002-17. doi: 10.18632/oncotarget.6760. Oncotarget. 2016. PMID: 26716904 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,495 results

Search Page

Filters